The presence of MEFV gene mutations in patients with primary osteoarthritis who require surgery
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background/Aims: Chronic arthritis of familial Mediterranean fever (FMF)involves weight-bearing joints and can occur in patients without a history of acute attack. Our aim was to investigate a possible causal relationship between FMF and osteoarthritis in a population in which FMF is quite common. Methods: Patients with late stage primary osteoarthritis were enrolled, and five MEFV gene mutations were investigated. The frequency of MEFV gene mutations was compared among patients with osteoarthritis and a previous healthy group from our center. Results: One hundred patients with primary osteoarthritis and 100 healthy controls were studied. The frequency of MEFV gene mutations was significantly lower in the osteoarthritis group (9% vs. 19%). M694V was the most frequent mutation (5%) in the osteoarthritis group, whereas in the control group, E148Q was the most common (16%). In subgroup analyses, the mutation frequency of patients with hip osteoarthritis was not different from that of patients with knee osteoarthritis and controls (7.1%, 9.7%, and 19%, respectively). There were no differences among the three groups with respect to MEFV gene mutations other than E148Q (8.1% vs. 3.6%). E148Q was significantly lower in the osteoarthritis group than in the controls (16% vs. 1%), although the mutations did not differ between patients with knee osteoarthritis and controls. Conclusions: In a population with a high prevalence of MEFV gene mutations, we did not find an increased mutation rate in patients with primary osteoarthritis. Furthermore, we found that some mutations were significantly less frequent in patients with osteoarthritis. Although the number of patients studied was insufficient to claim that E148Q gene mutation protects against osteoarthritis, the potential of this gene merits further investigation.
Abstract
Background/Aims: Chronic arthritis of familial Mediterranean fever (FMF)involves weight-bearing joints and can occur in patients without a history of acute attack. Our aim was to investigate a possible causal relationship between FMF and osteoarthritis in a population in which FMF is quite common. Methods: Patients with late stage primary osteoarthritis were enrolled, and five MEFV gene mutations were investigated. The frequency of MEFV gene mutations was compared among patients with osteoarthritis and a previous healthy group from our center. Results: One hundred patients with primary osteoarthritis and 100 healthy controls were studied. The frequency of MEFV gene mutations was significantly lower in the osteoarthritis group (9% vs. 19%). M694V was the most frequent mutation (5%) in the osteoarthritis group, whereas in the control group, E148Q was the most common (16%). In subgroup analyses, the mutation frequency of patients with hip osteoarthritis was not different from that of patients with knee osteoarthritis and controls (7.1%, 9.7%, and 19%, respectively). There were no differences among the three groups with respect to MEFV gene mutations other than E148Q (8.1% vs. 3.6%). E148Q was significantly lower in the osteoarthritis group than in the controls (16% vs. 1%), although the mutations did not differ between patients with knee osteoarthritis and controls. Conclusions: In a population with a high prevalence of MEFV gene mutations, we did not find an increased mutation rate in patients with primary osteoarthritis. Furthermore, we found that some mutations were significantly less frequent in patients with osteoarthritis. Although the number of patients studied was insufficient to claim that E148Q gene mutation protects against osteoarthritis, the potential of this gene merits further investigation.
참고문헌 (24)
- Lawrence RC, "Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States", Arthritis Rheum, 41, pp.778~799 (1998)
- Ehrlich GE, "Osteoarthritis beginning with inflammation. Definitions and correlations", JAMA, 232, pp.1975~1232 (1975)
- Heller H, "The arthritis of familial Mediterranean fever (FMF)", Arthritis Rheum, 9, pp.1~17 (1966)
- Garcia-Gonzalez A, "The arthritis of familial Mediterranean fever", Semin Arthritis Rheum, 22, pp.139~150 (1992)
- Sneh E, "Protracted arthritis in familial Mediterranean fever", Rheumatol Rehabil, 16, pp.102~106 (1977)
- Younes M, "Hip involvement in patients with familial Mediterranean fever: a review of ten cases", Joint Bone Spine, 69, pp.560~565 (2002)
- Bhat A, "Genetics and new treatment modalities for familial Mediterranean fever", Ann N Y Acad Sci, 1110, pp.201~208 (2007)
- Stehlik C, "The PAAD", PYRIN-family protein ASC is a dual regulator of a conserved step in nuclear factor kappaB activation pathways, 2002, pp.196, 1605~1615
- Booth DR, "Prevalence and significance of the familial Mediterranean fever gene mutation encoding pyrin Q148", QJM, 94, pp.527~531 (2001)
- Cosan F, "Association of familial Mediterranean fever-related MEFV gene M694V mutation with ankylosing spondylitis", Arthritis Rheum, 54, pp.465~466 (2006)
- Rabinovich E, "Severe disease in patients with rheumatoid arthritis carrying a mutation in the Mediterranean fever gene", Ann Rheum Dis, 64, pp.1009~1014 (2005)
- Rabinovich E, "Common FMF alleles may predispose to development of Behcet's disease with increased risk for venous thrombosis", Scand J Rheumatol, 36, pp.48~52 (2007)
- Giaglis S, "Increased frequency of mutations in the gene responsible for familial Mediterranean fever (MEFV) in a cohort of patients with ulcerative colitis: evidence for a potential disease-modifying effect?", Dig Dis Sci, 51, pp.687~692 (2006)
- Ozen S, "Mutations in the gene for familial Mediterranean fever: do they predispose to inflammation?", J Rheumatol, 30, pp.2014~2018 (2003)
- Neame RL, "Genetic risk of knee osteoarthritis: a sibling study", Ann Rheum Dis, 63, pp.1022~1027 (2004)
- Lanyon P, "Assessment of a genetic contribution to osteoarthritis of the hip: sibling study", BMJ, 321, pp.1179~1183 (2000)
- Valdes AM, "The contribution of genes to osteoarthritis", Med Clin North Am, 93, pp.45~66 (2009)
- Valdes AM, "The genetic epidemiology of osteoarthritis", Curr Opin Rheumatol, 22, pp.139~143 (2010)
- Tunca M, "Acute phase response and evolution of familial Mediterranean fever", Lancet, 353, pp.1415~ (1999)
- Lachmann HJ, "Clinical and subclinical inflammation in patients with familial Mediterranean fever and in heterozygous carriers of MEFV mutations", Rheumatology, 45, pp.746~750 (2006)
- Yilmaz E, "Mutation frequency of familial Mediterranean fever and evidence for a high carrier rate in the Turkish population", Eur J Hum Genet, 9, pp.553~555 (2001)
- Ben-Chetrit E, "The E148Q mutation in the MEFV gene: is it a disease-causing mutation or a sequence variant?", Hum Mutat, 15, pp.385~386 (2000)
- Tchernitchko D, "The E148Q MEFV allele is not implicated in the development of familial Mediterranean fever", Hum Mutat, 22, pp.339~340 (2003)
- Koc B, "The rate of pyrin mutations in critically ill patients with systemic inf lammatory response syndrome and sepsis: a pilot study", J Rheumatol, 34, pp.2070~2075 (2007)